Key Highlights
- Inbound Health closes a $30 million Series B funding round.
- Investment led by HealthQuest Capital with participation from Flare Capital Partners and McKesson Ventures.
- Funding to support expansion into new markets, advancement of clinical programs, and development of proprietary technology.
- Inbound Health’s models have shown reductions in length-of-stay, readmission rates, and complication rates.
Source: PR Web
Notable Quotes
- “We are excited to embark on this next phase of growth with the strong backing of our investors, led by HealthQuest Capital,” – Dave Kerwar, CEO of Inbound Health
- “Inbound Health’s innovative solution addresses a pressing need within our healthcare system… This is especially vital in light of the growing capacity challenges faced by hospitals,” – Garheng Kong, Managing Partner at HealthQuest Capital
SoH's Take
Inbound Health’s successful Series B funding round underscores the growing importance and potential of home-based healthcare solutions. As health systems increasingly recognize the home as a viable site for acute and post-acute care, companies like Inbound Health are poised to play a pivotal role in this transformation. The significant investment, led by HealthQuest Capital, is a testament to the value and promise of Inbound Health’s approach. Their focus on aligning economics through a value-based care approach and their commitment to advancing clinical, operational, and technological assets indicate a forward-thinking strategy. As the healthcare landscape evolves, especially in light of the challenges posed by the pandemic, solutions that prioritize patient comfort and experience, like those offered by Inbound Health, will likely become even more essential.
